• Covid, Gimbe: "The curve is inverted, + 43% new cases and hospitalizations increase"

  • Usa, green light for Pfizer vaccine for children.

    Biden: "We are at a turning point"

  • Covid.

    USA authorizes Pfizer vaccine for children between 5 and 11 years old

Share

04 November 2021

"By Christmas I think it's a reasonable hypothesis." So on Sky TG24 the president of the Superior Health Council, Franco Locatelli, about the campaign for the 5-11 year old age group with the Pfizer vaccine. "I believe that the EMA can reach an evaluation and an approval by the end of the month-first half of December. At that point we can leave there," he adds. And on safety: "Let's get rid of the concept very clearly, it is absolutely a safe vaccine, it is no coincidence that it received immediate approval from both the FDA and the CDC".

"When they will be approved in Italy, and consequently first in Europe, it will also have to be a choice in our country: in part, children must also be protected from the, albeit rare, serious or prolonged manifestations of Covid, also to allow them to have all the spaces of sociality they deserve and to help reduce viral circulation. I think there are very good reasons for vaccinating children, "says Locatelli.

There is also an unvaccinated pandemic risk in Italy


The declaration by the German Minister of Health, Jens Spahn, regarding an unvaccinated pandemic "has a big foundation because most of those infected are unvaccinated people", adds the president of the Superior Health Council.

A danger that could also exist in Italy "because, obviously, viral circulation is also present in our country".

Aifa applauds the decision on Johnson & Johnson


The Aifa "absolutely deserves praise for its timeliness, clarity and incisiveness of the provision. Yesterday it was decided by our regulatory agency to offer the booster dose to those vaccinated with Johnson & Johnson regardless of age, precisely on the basis of the scientific evidence available. done six months after vaccination with J&J using the Pfizer vaccine or the Moderna vaccine, then the two RNA vaccines we have available in the country. The Moderna vaccine, however, and we say it clearly so we avoid some improper and inappropriate speculation. it will be used at half dose, as only used in the booster dose: half dose which, however, is still characterized by a messenger RNA content higher than that of Pfizer "concludes Locatelli.

In these same hours,

the circular of the extraordinary commissioner Figliuolo to the Regions

with the indications to the governors on the continuation of the vaccination campaign.

Third dose "without delay from the sixth month"